Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
7.52
+0.58 (8.36%)
At close: Apr 28, 2026, 4:00 PM EDT
7.52
0.00 (0.00%)
Pre-market: Apr 29, 2026, 6:50 AM EDT
Wave Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,447 | 3,111 | 1,887 | 602 | 608 | 185 | |
| Market Cap Growth | 72.00% | 64.89% | 213.59% | -1.10% | 229.32% | -51.88% | |
| Enterprise Value | 918 | 2,942 | 1,611 | 503 | 533 | 95 | |
| Last Close Price | 7.52 | 17.00 | 12.37 | 5.05 | 7.00 | 3.14 | |
| PS Ratio | 20.15 | 72.81 | 17.42 | 5.31 | 166.72 | 4.51 | |
| PB Ratio | 2.83 | 5.91 | 8.68 | 12.67 | -16.35 | 4.58 | |
| P/TBV Ratio | 2.83 | 6.00 | 9.01 | 15.18 | - | 5.68 | |
| EV/Sales Ratio | 12.78 | 68.86 | 14.87 | 4.44 | 146.02 | 2.33 | |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.12 | 0.68 | -1.01 | 0.74 | |
| Net Debt / Equity Ratio | -1.03 | -1.11 | -1.27 | -3.54 | 1.37 | -2.99 | |
| Net Debt / EBITDA Ratio | 2.73 | 2.76 | 2.60 | 2.67 | 0.33 | 1.01 | |
| Net Debt / FCF Ratio | 2.86 | 3.11 | 1.82 | 8.19 | 0.39 | 1.35 | |
| Asset Turnover | 0.17 | 0.09 | 0.35 | 0.54 | 0.02 | 0.17 | |
| Quick Ratio | 10.93 | 6.35 | 2.74 | 1.19 | 1.24 | 2.35 | |
| Current Ratio | 11.26 | 6.47 | 2.89 | 1.26 | 1.38 | 2.53 | |
| Return on Equity (ROE) | -53.11% | -54.97% | -73.24% | -1118.17% | -10258.19% | -186.60% | |
| Return on Assets (ROA) | -28.23% | -27.18% | -22.00% | -20.17% | -57.56% | -32.65% | |
| Return on Capital Employed (ROCE) | -36.90% | -39.60% | -45.80% | -76.80% | -217.40% | -88.90% | |
| Earnings Yield | -12.69% | -6.57% | -5.14% | -9.56% | -26.60% | -66.17% | |
| FCF Yield | -12.79% | -6.05% | -8.05% | -3.42% | -21.23% | -48.48% | |
| Buyback Yield / Dilution | -21.45% | -21.96% | -30.33% | -34.55% | -52.16% | -32.12% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.